Innovative use of Lebanese Milk thistle (Silybum Marianum) extract as a natural antioxidant and antitumor agent for the treatment of prevention of lymphoma cancer.

LB13365BUndetermined Publication Date: 2026-07-30MRS RAWAN SALEH +4
0 Cites 0 Cited by

Patent Information

Application Number
LB13365
Authority / Receiving Office
LB · LB
Patent Type
Patents
Current Assignee / Owner
Filing Date
2025-08-07
Publication Date
2026-07-30
Estimated Expiration
2045-08-07
Patent Text Reader

Abstract

Lymphoma is a group of cancers that originate This thesis investigates the antioxidant and anticancer effects of wild milk thistle extracts on lymphocytes. The seed extract (PEL) showed primary effusion. Wild artichoke with ethanol has the highest concentration of phenolic and flavonoid compounds, giving it the strongest activity. DPPH is an antioxidant with a 97.4% effectiveness rating according to testing. The biological evidence that MTT extracts clearly tested BC3 PEL cancer cells inhibit cell proliferation. In a manner independent of dose or time. The results suggest that the seeds and leaves of milk thistle may act as natural antioxidants with potential antiproliferative properties.
Need to check novelty before this filing date? Find Prior Art